Hasil Pencarian - Serena Merante
- Menampilkan 1 - 3 hasil dari 3
-
1
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience... oleh Francesca Palandri, Fausto Castagnetti, Giuliana Alimena, Nicoletta Testoni, Massimo Breccia, Simona Luatti, Giovanna Rege-Cambrin, Fabio Stagno, Giorgina Specchia, Bruno Martino, Luciano Levato, Serena Merante, Anna Maria Liberati, Fabrizio Pane, Giuseppe Saglio, Daniele Alberti, Giovanni Martinelli, Michele Baccarani, Gianantonio Rosti
Diterbitkan 2009-02-01Dapatkan teks lengkap
Artikel -
2
P872: EFFICACY OF DARATUMUMAB PLUS BORTEZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA PRESENTING WITH EXTRAMEDULLARY DISEASE: A EUROPEAN MYELOMA NETWO... oleh Meral Beksac, Tulin Tuglular, Francesca Gay, Roberto Mina, Eirini Katodritou, Ali Unal, Michele Cavo, Guner Hayri Ozsan, Vincent H.J. van der Velden, Berna Beverloo, Michael Vermeulen, Mark van Duin, Guldane Cengiz, Omur Gokmen Sevindik, Serena Merante, Kyriaki Manousou, Pieter Sonneveld, Evangelos Terpos
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
3
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study oleh Michele Baccarani, Daniela Cilloni, Michela Rondoni, Emanuela Ottaviani, Francesca Messa, Serena Merante, Mario Tiribelli, Francesco Buccisano, Nicoletta Testoni, Enrico Gottardi, Antonio de Vivo, Emilia Giugliano, Ilaria Iacobucci, Stefania Paolini, Simona Soverini, Gianantonio Rosti, Francesca Rancati, Cinzia Astolfi, Fabrizio Pane, Giuseppe Saglio, Giovanni Martinelli
Diterbitkan 2007-09-01Dapatkan teks lengkap
Artikel